Shenzhen Salubris Pharmaceuticals (szse: 002294) is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.[1]
Shenzhen Salubris is headed by the billionaire Ye Chenghai.[2]
References
- Shenzhen Salubris Pharmaceuticals Forbes, retrieved 6 April 2019^
- Ye Chenghai Forbes, retrieved 16 May 2015^